Log In
Print
BCIQ
Print
Print this Print this
 

Scenesse, afamelanotide (CUV1647) (formerly Melanotan)

Also known as: formerly EPT1647 implant

  Manage Alerts
Collapse Summary General Information
Company Clinuvel Pharmaceuticals Ltd.
DescriptionSustained-release subcutaneous implant of synthetic alpha melanocyte stimulating hormone (MSH)
Molecular Target Melanocortin 1 receptor (MC1R)
Mechanism of ActionMelanocortin 1 receptor (MC1R) agonist
Therapeutic ModalityMedical Devices: Drug/device combination

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today